HVCN1

Voltage-gated hydrogen channel 1 · Q96D96 · HVCN1 on Sugi Atlas →

0 patent compounds predicted against HVCN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HVCN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome PHASE3RECRUITING
An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome PHASE1/PHASE2COMPLETED
A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome PHASE1/PHASE2NOT_YET_RECRUITING
4-Aminopyridine in Episodic Ataxia Type 2 PHASE2WITHDRAWN
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve PHASE2UNKNOWN
StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 PHASE2RECRUITING
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies PHASE2WITHDRAWN
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss PHASE2COMPLETED
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours PHASE1COMPLETED
Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor PHASE1RECRUITING
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Factors Affecting Salt Intake in Young Adults nanUNKNOWN
The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain. nanUNKNOWN
Evaluation of the Effects of KCNQ1 Mutation on Insulin Tolerance and Obsessive Compulsive Features in Long QT Romano-Ward Syndrome Patients. nanUNKNOWN
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants nanRECRUITING
The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism nanCOMPLETED
Classical Trigeminal Neuralgia and Sodium Channel Mutations nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia nanCOMPLETED
The Energetic Origin of Neurodegeneration in MS nanCOMPLETED
Sodium Channel Splicing in Heart Failure Trial nanCOMPLETED
Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study nanUNKNOWN
Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services nanUNKNOWN
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP nanRECRUITING
Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures nanCOMPLETED
The Use of Antiarrhythmic Drugs in Pediatrics nanUNKNOWN
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients nanNOT_YET_RECRUITING
Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor nanUNKNOWN
Multidisciplinary Study of Right Ventricular Dysplasia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HVCN1 binder may also engage these)

ProteinNameSimilarity
Q3U2S8 0.993 Q3U2S8 →
Q5F4C0 0.990 Q5F4C0 →
Q5M7E9 0.980 Q5M7E9 →
Q5M8L8 0.968 Q5M8L8 →
Q9N0B5 0.968 Q9N0B5 →
Q2M3C6 0.966 Q2M3C6 →
O62826 0.964 O62826 →
Q6P8G8 0.963 Q6P8G8 →
Q4GZT3 0.962 Q4GZT3 →
D4A6L0 0.962 D4A6L0 →
Q8BZN2 0.961 Q8BZN2 →
D3ZWZ9 0.961 D3ZWZ9 →
E1BBQ2 0.961 E1BBQ2 →
Q5ZKN3 0.960 Q5ZKN3 →
Q9R283 0.960 Q9R283 →
A0JPH4 0.960 A0JPH4 →
Q49LS8 0.960 Q49LS8 →
KCND3 A-type voltage-gated potassium channel KCND3 0.960 landscape →
O73606 0.958 O73606 →
Q5M7W4 0.958 Q5M7W4 →
Q9WTN5 0.957 Q9WTN5 →
Q6PIU1 0.957 Q6PIU1 →
Q5RC10 0.957 Q5RC10 →
Q496Y0 0.957 Q496Y0 →
Q8BZB3 0.956 Q8BZB3 →
KCNN1 Small conductance calcium-activated potassium channel protein 1 0.956 landscape →
Q8BKU8 0.956 Q8BKU8 →
Q9TTT5 0.956 Q9TTT5 →
Q6GQE1 0.956 Q6GQE1 →
O88703 0.956 O88703 →